Research Article
RP-HPLC Method Development and Validation of Synthesized Codrug in Combination with Indomethacin, Paracetamol, and Famotidine
Table 4
Results of the robustness at different variable parameters.
| | FAM | PAR | IND | Codrug |
| The wavelength of maximal absorption (λmax) | 273 nm | Av. area | 4279022 | 2357627 | 7713100 | 4191009 | 275 nm | Av. area | 4225523 | 2324816 | 7797471 | 4109888 | 277 nm | Av. area | 4263527 | 2374482 | 7759887 | 4186203 | | % RSD | 0.65 | 1.07 | 0.54 | 1.09 |
| Mobile pH | pH 5.1 | Av. area | 4353746 | 2280521 | 7609836 | 4089088 | pH 4.9 | Av. area | 4355659 | 2247925 | 7803400 | 4177253 | pH 5.0 | Av. area | 4225523 | 2324816 | 7797471 | 4109888 | | % RSD | 1.73 | 1.69 | 1.42 | 1.12 |
| Flow rate | Flow rate of 1.2 mL/min. | Av. area | 4289108 | 2336035 | 7620148 | 4220573 | Flow rate of 1.4 mL/min. | Av. area | 4225523 | 2324816 | 7797471 | 4109888 | | % RSD | 1.06 | 0.34 | 1.63 | 1.88 |
|
|